期刊文献+

系统性红斑狼疮的治疗进展

下载PDF
导出
摘要 本文对近年来SLE的药物治疗、免疫治疗、免疫球蛋白静脉滴注、血液净化、造血干细胞移植术等方面的进展情况进行综述。阐明应根据患者免疫紊乱状态、器官受累、病情轻重、病程等情况综合考虑,采取个体化的治疗方案。
出处 《中国麻风皮肤病杂志》 2005年第2期117-119,共3页 China Journal of Leprosy and Skin Diseases
  • 相关文献

参考文献20

  • 1Musso M, Porretto F, Crescimanno A, et al. Intense immunesuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune diseases. Bone Marrow Transplant 2001 ;28:1 - 12.
  • 2Amal C, Piette JC, Leone J, et al. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cascs. J Rheumatol 2002; 29: 75 - 83.
  • 3Levy RA, Vilela VS, Cataldo MJ, et al. Hydroxychloroquine(HCQ)in lupus pregnancy: double- blind and placebo- controlled sludy.Lupus 2001 ; 10:401 - 404.
  • 4Alvarez N J, Cobarrubias CA, Escalante TF. Bromocriptine in systemic lupus erythematosus: a double- blind, randomized, placebocontrolled study. Lupus 1998;7:414- 419.
  • 5Housman TS, Jorizzo JL, McCarty MA, et a]. Low- dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus.Arch Dermatol 2003; 139:50 - 54.
  • 6Sthoeger ZM, Zinger H, Mozes E. Beneficial effects of the antioestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibidies. Ann Rheum Dis 2003;62:341 - 346.
  • 7Wu WM, Lin BF, Su YC, et al. Tamoxifen decreases renal inflammarion and alleviates disease severity in autoimmune NZB/W F1 mice. Scand J Immunol 2000;52:393 - 400.
  • 8Chang DM, Lan JL, Lin HY, et al. Dehydroepiandrosterone treatment of women with mild - to - moderate systemic lupus erythematosus: a multicenter randomized, double- blind, placebo - controlled trial. Arthritis Rheum 2002;46:2924- 2927.
  • 9Petri MA, Lahita RG, Van Vollenhoven RF, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double - blind, randomized, placebo - controlled trial.Arthritis Rheum 2002;46:1820 - 1829.
  • 10Boumpas DT, Furie R, Manzi S, et al. A short course of BG9588(anti- CIMO ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum 2003;48:719 - 727.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部